4//SEC Filing
Tibira Therapeutics, Inc. 4
Accession 0000904454-15-000266
CIK 0001311596operating
Filed
May 5, 8:00 PM ET
Accepted
May 6, 5:35 PM ET
Size
17.8 KB
Accession
0000904454-15-000266
Insider Transaction Report
Form 4
DOVEY BRIAN H
10% Owner
Transactions
- Other
Common Stock
2015-05-04+36,187→ 38,094 total
TREU JESSE I
Director10% Owner
Transactions
- Other
Common Stock
2015-05-04+36,187→ 38,094 total
Halak Brian K
10% Owner
Transactions
- Other
Common Stock
2015-05-04+36,187→ 38,094 total
Kamdar Kim P.
10% Owner
Transactions
- Other
Common Stock
2015-05-04+36,187→ 38,094 total
DOMAIN ASSOCIATES
10% Owner
Transactions
- Other
Common Stock
2015-05-04+36,187→ 38,094 total
BLAIR JAMES C
10% Owner
Transactions
- Other
Common Stock
2015-05-04+36,187→ 38,094 total
SCHOEMAKER KATHLEEN K
10% Owner
Transactions
- Other
Common Stock
2015-05-04+36,187→ 38,094 total
VITULLO NICOLE
10% Owner
Transactions
- Other
Common Stock
2015-05-04+36,187→ 38,094 total
Footnotes (7)
- [F1]The securities reported as directly beneficially owned by the designated Reporting Person may be deemed to be indirectly beneficially owned by each of the Reporting Owners listed below, each of whom is a managing member of the designated Reporting Person. Pursuant to Instruction 4(b)(iv) of Form 4, each such individual has elected to report as indirectly beneficially owned the entire number of securities owned by the designated Reporting Person, however each of them disclaims beneficial ownership of any securities, and any proceeds thereof, that exceed his or her pecuniary interest therein and/or that are not actually distributed to him or her.
- [F2]As managing members of the sole general partner of DP VII Associates, L.P., each Reporting Owner listed below (except for Kim P. Kamdar) may also be deemed to indirectly beneficially own 47,613 shares of Common Stock held by DP VII Associates, L.P. Pursuant to Instruction 4(b)(iv) of Form 4, each such individual has elected to report as indirectly beneficially owned the entire number of securities owned by DP VII Associates, L.P, however each of them disclaims beneficial ownership of any securities, and any proceeds thereof, that exceed his or her pecuniary interest therein and/or that are not actually distributed to him or her.
- [F3]As managing members of the sole general partner of Domain Partners VI, L.P., each Reporting Owner listed below (except for Brian K. Halak and Kim P. Kamdar) may also be deemed to indirectly beneficially own 285,679 shares of Common Stock held by Domain Partners VI, L.P. Pursuant to Instruction 4(b)(iv) of Form 4, each such individual has elected to report as indirectly beneficially owned the entire number of securities owned by Domain Partners VI, L.P, however each of them disclaims beneficial ownership of any securities, and any proceeds thereof, that exceed his or her pecuniary interest therein and/or that are not actually distributed to him or her.
- [F4]As managing members of the sole general partner of DP VI Associates, L.P., each Reporting Owner listed below (except for Brian K. Halak and Kim P. Kamdar) may also be deemed to indirectly beneficially own 1,657 shares of Common Stock held by DP VI Associates, L.P. Pursuant to Instruction 4(b)(iv) of Form 4, each such individual has elected to report as indirectly beneficially owned the entire number of securities owned by DP VI Associates, L.P, however each of them disclaims beneficial ownership of any securities, and any proceeds thereof, that exceed his or her pecuniary interest therein and/or that are not actually distributed to him or her.
- [F5]As managing members of the sole general partner of Domain Partners VII, L.P., each Reporting Owner listed below (except for Kim P. Kamdar) may also be deemed to indirectly beneficially own3,553,322 shares of Common Stock held by Domain Partners VII, L.P. Pursuant to Instruction 4(b)(iv) of Form 4, each such individual has elected to report as indirectly beneficially owned the entire number of securities owned by Domain Partners VII, L.P., however each of them disclaims beneficial ownership of any securities, and any proceeds thereof, that exceed his or her pecuniary interest therein and/or that are not actually distributed to him or her.
- [F6]Received in exchange for 25,302 shares of Tobira Therapeutics, Inc. ("Tobira") common stock in connection with the merger of Landmark Merger Sub Inc., a wholly owned subsidiary of the Issuer (then named Regado Biosciences, Inc.) with and into Tobira, with Tobira surviving as a wholly owned subsidiary of the Issuer (the "Merger"). Each share of Tobira common stock outstanding immediately prior to the Merger was converted into the right to receive approximately 11.4521 shares of Common Stock. After the completion of the Merger, the Issuer changed its name to "Tobira Therapeutics, Inc."
- [F7]The number of shares of Common Stock held by the designated Reporting Person prior to the Merger is adjusted to reflect the one-for-nine reverse split of the Common Stock that was effective prior to the Merger.
Documents
Issuer
Tibira Therapeutics, Inc.
CIK 0001311596
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001311596
Filing Metadata
- Form type
- 4
- Filed
- May 5, 8:00 PM ET
- Accepted
- May 6, 5:35 PM ET
- Size
- 17.8 KB